EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Human UC-MSC-derived exosomes facilitate ovarian renovation in rats with chemotherapy-induced premature ovarian insufficiency

Xiaodi Pu, Leisheng Zhang, Peiyu Zhang, Yaqiong Xu, Jun Wang, Xiaomei Zhao, Zhihua Dai, Hua Zhou, Shuyun Zhao, Anran Fan

Frontiers in Endocrinology · 2023

DOI: 10.3389/fendo.2023.1205901 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Endocrinology, 2023. Verfasst von Xiaodi Pu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Guizhou Medical University, Guiyang, China. Hauptthemen laut MEDLINE: Exosomes, Primary Ovarian Insufficiency, Menopause, Premature, Antineoplastic Agents. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Premature ovarian insufficiency (POI) induced by chemotherapy is an intractable disorder with a considerable incidence that commonly results in insufficient fertility and concomitant complications in female patients. Due to limitations in the current progress in POI diagnosis and treatment, there is an urgent need to develop novel remedies to improve ovarian function and protect fertility. The ameliorative effect of human umbilical cord mesenchymal stem cells (hUCMSCs) and exosomes derived from them in POI treatment could be a new hope for patients. Herein, we identified exosomes from hUCMSCs (hUCMSC-Exos). Then, systematic infusion of hUCMSC-Exos was accomplished via tail intravenous injection to investigate the feasibility of the treatment of rats with chemotherapy-induced POI by intraperitoneal injection of cyclophosphamide (CTX) and busulfan (BUS). Ovarian functions in the indicated group were evaluated, including oestrous cycle, serum sex hormone levels, follicle counts, ovarian pathological changes, proliferation and apoptosis of granulosa cells (GCs), and reproductive ability testing. Furthermore, the potential influence of hUCMSC-Exos on ovarian tissues was illuminated by conducting RNA-seq and multifaceted bioinformatics analyses. POI rats with hUCMSC-Exos transplantation exhibited a decrease in follicle-stimulating hormone (FSH) and apoptosis of GCs but an increase in oestradiol (E2), anti-Müllerian hormone (AMH), and the number of ovarian follicles and foetuses in the uterus. And the immunomodulation- and cellular vitality-associated gene sets in rats had also undergone moderate changes. Our data indicated the feasibility of hUCMSC-Exos in improving ovarian function and protecting fertility in chemotherapy-induced POI rats. HUCMSC-Exos can improve the local microenvironment of ovarian tissue in POI rats by participating in immune regulation, cellular viability, inflammation regulation, fibrosis and metabolism, and other related signal pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExosomesPrimary Ovarian InsufficiencyMenopause, PrematureAntineoplastic AgentsRatsHumansFemaleAnimals

Stichwörter der Autor:innen

HUCMSCsexosomesgene expression profileovarian functionpremature ovarian insufficiency (POI)

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Guizhou Medical University, Guiyang, China.
  • Stem Cell Bank of Guizhou Province, Guizhou Health-Biotech Biotechnology Co., Ltd., Guiyang, China.
  • Key Laboratory of Molecular Diagnostics and Precision Medicine for Surgical Oncology in Gansu Province, Gansu Provincial Hospital, Lanzhou, China.
  • National Health Commission (NHC) Key Laboratory of Diagnosis and Therapy of Gastrointestinal Tumor, Gansu Provincial Hospital, Lanzhou, China.
  • Key Laboratory of Radiation Technology and Biophysics, Hefei Institute of Physical Science, Chinese Academy of Sciences, Hefei, China.
  • Reproductive Medicine Center, Department of Obstetrics and Gynecology of the Affiliated Hospital of Guizhou Medical University, Guiyang, China.

Zitieren

APA

Pu, X., Zhang, L., Zhang, P., Xu, Y., Wang, J., Zhao, X., Dai, Z., Zhou, H., Zhao, S., & Fan, A. (2023). Human UC-MSC-derived exosomes facilitate ovarian renovation in rats with chemotherapy-induced premature ovarian insufficiency. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2023.1205901

Vancouver

Pu X, Zhang L, Zhang P, Xu Y, Wang J, Zhao X, et al. Human UC-MSC-derived exosomes facilitate ovarian renovation in rats with chemotherapy-induced premature ovarian insufficiency. Frontiers in Endocrinology. 2023. doi:10.3389/fendo.2023.1205901

BibTeX
@article{Pu2023,
  author = {Pu, Xiaodi and Zhang, Leisheng and Zhang, Peiyu and Xu, Yaqiong and Wang, Jun and Zhao, Xiaomei and Dai, Zhihua and Zhou, Hua and Zhao, Shuyun and Fan, Anran},
  title = {Human UC-MSC-derived exosomes facilitate ovarian renovation in rats with chemotherapy-induced premature ovarian insufficiency},
  journal = {Frontiers in Endocrinology},
  year = {2023},
  doi = {10.3389/fendo.2023.1205901}
}
Kostenlos starten →